Leading the Way in Life Science Technologies

GEN Exclusives

More »

Market and Technology Analysis

More »
Aug 13, 2013

Eye on Next-Generation Sequencing

This article discusses the NGS research space and the most recent market trends associated with it.

Eye on Next-Generation Sequencing

Three hotspot maps on next-generation sequencing-focused publications are included in this incisive report.

  • The focus of this GEN Market & Tech Analysis Report is to characterize the next-generation sequencing (NGS) space based on the following classes of data, which we have been collecting as part of our industry analysis of this field:

    • Publications growth
    • Hotspot analysis of publications illustrating research areas and segments where these publications coalesce/penetrate
    • Reagents and kits commercially available → Sampling from selected companies in the space
    • Sampling of selected NGS-based tests for clinical applications/patient testing → NGS as a means to enable personalized medicine

    CLICK HERE to download the PDF report.

Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »